Prilosec OTC Continues To Gain Share Amid Advertising, Supply Pressures
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble says sales of Prilosec OTC will face difficult year-over-year comparisons in the current quarter, indicating that growth for the heartburn drug may be slowing